Factors influencing completion of treatment among pulmonary tuberculosis patients

References

• Berry MPR, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010;466(7309):973–977. doi:10.1038/nature0924720725040
   PubMed Web of Science ®Google Scholar
• Lyon SM, Rossman MD. Pulmonary tuberculosis. Microbiol Spectr. 2017;5:1. doi:10.1128/microbiolspec.TNMI7-0032-2016
   Web of Science ®Google Scholar
• Zhang, Y., Wang Xl, Feng T, Fang Cz. Analysis of spatial-temporal distribution and influencing factors of pulmonary tuberculosis in China, during 2008–2015. Epidemiol Infect. 2018;10:1–9.
   Google Scholar
• Li T, Zhang H, Shewade HD, Soe KT, Wang L, Du X. Patient and health system delays before registration among migrant patients with tuberculosis who were transferred out in China. BMC Health Serv Res. 2018;18(1):786. doi:10.1186/s12913-018-3583-y30340489
   PubMed Web of Science ®Google Scholar
• Davies FL, Niward K, Hu Y, et al. Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study. BMJ Open. 2018;8(9):e023899. doi:10.1136/bmjopen-2018-023899
   Web of Science ®Google Scholar
• Kadhiravan T. Adherence and acquired drug-resistance in tuberculosis: wisdom stood on its head. Indian J Chest Dis Allied Sci. 2013;55(1):9–10.23798083
   PubMedGoogle Scholar
• Kidenya BR, Mshana SE, Gerwing-Adima L, Kidola J, Kasang C. Drug adherence and efficacy of smear microscopy in the diagnosis of pulmonary tuberculosis after 2 months of medication in North-western Tanzania. Int J Infect Dis. 2017;63:43–47. doi:10.1016/j.ijid.2017.07.02528782605
   PubMed Web of Science ®Google Scholar
• Cadosch D, Guerrero P, Briscoe J, Page KM. The role of adherence and retreatment in De Novo emergence of MDR-TB. PLoS Comput Biol. 2016;12(3):e1004749. doi:10.1371/journal.pcbi.100515426967493
   PubMed Web of Science ®Google Scholar
• Seung KJ, Keshavjee S, Rich ML, Tuberculosis M-R. Extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med. 2015;5(9):a017863. doi:10.1101/cshperspect.a01786325918181
   PubMed Web of Science ®Google Scholar
• Hirpa S, Medhin G, Girma B, et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health. 2013;13:782. doi:10.1186/1471-2458-13-78223981845
   PubMed Web of Science ®Google Scholar
• DiStefano MJ, Schmidt H. mHealth for tuberculosis treatment adherence: a framework to guide ethical planning, implementation, and evaluation. Glob Health Sci Pract. 2016;4(2):211–221. doi:10.9745/GHSP-D-16-0001827353615
   PubMed Web of Science ®Google Scholar
• Gebremariam MK, Bjune GA, Frich JC. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health. 2010;10:651. doi:10.1186/1471-2458-10-65121029405
   PubMed Web of Science ®Google Scholar
• Kebede A, Wabe NT. Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South west ethiopia. N Am J Med Sci. 2012;4(2):67–71. doi:10.4103/1947-2714.9337622408750
   PubMedGoogle Scholar
• Metcalfe JZ, O’Donnell MR, Bangsberg DR. Moving beyond directly observed therapy for tuberculosis. PLoS Med. 2015;12(9):e1001877. doi:10.1371/journal.pmed.100180926372602
   PubMed Web of Science ®Google Scholar
• Wei X-L, Yin J, Zou G-Y, et al. Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China. Int J Tuberc Lung Dis. 2015;19(4):413–419. doi:10.5588/ijtld.14.048525859996
   PubMed Web of Science ®Google Scholar
• Choowong J, Tillgren P, Söderbäck M. Thai people living with tuberculosis and how they adhere to treatment: a grounded theory study. Nurs Health Sci. 2017;19(4):436–443. doi:10.1111/nhs.1236228719050
   PubMed Web of Science ®Google Scholar
• Yin J, Wang X, Zhou L, Wei X. The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study. Trop Med Int Health. 2018;23(6):668–677. doi:10.1111/tmi.1306629691959
   PubMed Web of Science ®Google Scholar
• Shargie EB, Lindtjorn B. Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med. 2007;4(2):e37. doi:10.1371/journal.pmed.004003717298164
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(6):521–528. doi:10.1097/MLR.0b013e318032937e17515779
   PubMed Web of Science ®Google Scholar
• Long Q, Smith H, Zhang T, Tang S, Garner P. Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health. 2011;11:393. doi:10.1186/1471-2458-11-39321615930
   PubMed Web of Science ®Google Scholar
• Wares DF, Singh S, Acharya AK, Dangi R. Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal. Int J Tuberc Lung Dis. 2003;7(4):327–335.12729337
   PubMed Web of Science ®Google Scholar
• Jaiswal A, Singh V, Ogden JA, et al. Adherence to tuberculosis treatment: lessons from the urban setting of Delhi, India. Trop Med Int Health. 2003;8(7):625–633.12828545
   PubMed Web of Science ®Google Scholar
• Sun Q, Meng Q, Yip W, Yin X, Li H. DOT in rural China: experience from a case study in Shandong Province, China. Int J Tuberc Lung Dis. 2008;12(6):625–630.18492328
   PubMed Web of Science ®Google Scholar
• Hu D, Liu X, Chen J, et al. Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan. 2008;23(1):43–55. doi:10.1093/heapol/czm03818156634
   PubMed Web of Science ®Google Scholar